secwatch / observer
8-K filed May 27, 2026, 4:45 PM ET ticker MDCX CIK 0001997296
debt confidence high sentiment negative materiality 0.80

Medicus Pharma closes $22M secured notes with Streeterville; receives Nasdaq MVLS non-compliance notice

Medicus Pharma Ltd.

item 1.01item 2.03item 3.01item 9.01
Featured in Daily 8-K Digest
Selected #7 for 2026-05-27. Read digest

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001062993-26-002900
form_type
8-K
ticker
MDCX
cik
0001997296
company_name
Medicus Pharma Ltd.
filed_at
2026-05-27T20:45:00+00:00
discovered_at
2026-05-27T20:46:00.253259+00:00
generated_at
2026-05-27T20:47:48.649387+00:00
sec_items
["1.01", "2.03", "3.01", "9.01"]
event_type
debt
sentiment
negative
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001062993-26-002900
json_url
https://secwatch.observer/filing/0001062993-26-002900.json
markdown_url
https://secwatch.observer/filing/0001062993-26-002900.md
text_url
https://secwatch.observer/filing/0001062993-26-002900.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/form8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

c82acdec964b29c636cf58309c902970a1b95a16

Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3), 5810(c)(3)(C)).

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

SEC 8-K Item 3.01 confidence 0.95 SEC evidence

Comparable filings

SONM

DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider

DNA X, Inc. May 27, 2026, 4:35 PM ET regulatory Items 1.01, 2.03, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 2.03, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests a hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting

Filing page SEC filing

PFSA

Profusa faces Nasdaq delisting for MVPHS failure; amends debt and warrant terms

Profusa, Inc. April 29, 2026, 7:59 PM ET regulatory Items 1.01, 2.03, 3.03, 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 2.03, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

April 28, 2026, the Company received written notification from the Nasdaq Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company had not regained compliance with Na

Filing page SEC filing

XHLD

TEN Holdings receives Nasdaq equity deficiency notice; issues 500k shares for $500k

TEN Holdings, Inc. May 26, 2026, 4:05 PM ET regulatory Items 1.01, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

May 26, 2026, the Company received a deficiency letter from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasda

Filing page SEC filing

ISPC

iSpecimen prices $2.5M private placement at $5.12/share; regains Nasdaq minimum bid price compliance

iSpecimen Inc. May 13, 2026, 5:00 PM ET other_material Items 1.01, 3.01, 3.02, 7.01, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for the prior 30 consecutive business days. On May 12, 2026

Filing page SEC filing

PMI

Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity

Picard Medical, Inc. May 11, 2026, 5:08 PM ET other_material Items 1.01, 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

May 8, 2026, the Company received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice states that the Company reported a stockholders’ equity of approximately $3.8 million as of

Filing page SEC filing

SBEV

Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M

SPLASH BEVERAGE GROUP, INC. May 5, 2026, 7:59 PM ET regulatory Items 1.01, 1.02, 3.01, 3.02, 5.03, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”) that the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined in Section 1

Filing page SEC filing

LNAI

Lunai Bioworks completes merger to acquire CNS patent portfolio; issues $20M Series B Preferred Stock

Lunai Bioworks Inc. May 1, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 9.01, 3.01, 3.02, 3.03, 5.03

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

April 20, 2026, the Company received notice from the Panel (in the “Decision”) that it had until April 27, 2026, to regain compliance with the $2.5 million equity requirement under Nasdaq Listing Rule 5550(b)(1) (the “S

Filing page SEC filing

DRCT

DRCT enters $50M equity line with Roth, terminates New Circle ELOC, receives Nasdaq delisting notice

Direct Digital Holdings, Inc. April 28, 2026, 7:59 PM ET other_material Items 1.01, 1.02, 3.01, 3.03, 5.03, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 similar materiality

This filing

May 20, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit

Comparable filing

April 23, 2026, the Company received an Additional Staff Delisting Determination Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in comp

Filing page SEC filing

Source: SEC EDGAR
accession 0001062993-26-002900
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.